Skip to main content
Gem Aromatics Limited logo

Gem Aromatics Limited — Investor Relations & Filings

Ticker · GEMAROMA ISIN · INE06XZ01023 LEI · 335800ZZAE23XEGGOB31 BSE.NS Manufacturing
Filings indexed 120 across all filing types
Latest filing 2025-12-11 Capital/Financing Update
Country IN India
Listing BSE.NS GEMAROMA

About Gem Aromatics Limited

https://gemaromatics.com/

Gem Aromatics Limited is a manufacturer and exporter specializing in aroma chemicals, essential oils, and menthol-based products. The company’s core portfolio includes menthol crystals, peppermint oil, spearmint oil, and various natural essential oils. These products serve as critical ingredients for the pharmaceutical, food and beverage, cosmetic, and fragrance sectors. The organization maintains a focus on quality assurance through standardized processing and distillation techniques, ensuring compliance with international safety and purity requirements. Its operations are geared toward providing consistent aromatic compounds and natural extracts to a global client base, supporting diverse industrial formulations.

Recent filings

Filing Released Lang Actions
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release dated December 11, 2025, announcing the commencement of commercial production of new products at a manufacturing facility of Gem Aromatics Limited. It is addressed to stock exchanges under SEBI regulations and includes a business update about operational expansion. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is a business update announcement and press release rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a report publication announcement since it contains substantive business update content rather than just announcing a report release. The best fitting category is Capital/Financing Update (CAP) as it relates to operational expansion and business growth announcements under regulatory disclosure requirements.
2025-12-11 English
Commencement of commercial production/operations
Capital/Financing Update Classification · 95% confidence The document is a press release dated December 11, 2025, announcing the commencement of commercial production at a new manufacturing facility of GEM Aromatics Limited. It is addressed to stock exchanges and references compliance with SEBI regulations. The content focuses on a business update about production capabilities and product portfolio expansion. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is a business update announcement and press release rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is also not a Management or Board change announcement, nor a voting result or capital change. The best fitting category is Capital/Financing Update (CAP) because it relates to a significant business operation update involving production capacity expansion and subsidiary activity, which is often classified under capital or business updates in regulatory disclosures under SEBI Regulation 30. The document length (7104 characters) and content confirm it is a substantive announcement, not just a brief notice or report publication announcement.
2025-12-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter dated December 4, 2025, addressed to stock exchanges (BSE and NSE) regarding the schedule of investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The letter informs about upcoming investor meetings and mentions that the Investor Presentation for Q2 & H1FY26 is already publicly available and will be used during these meetings. The document does not contain any financial statements, detailed financial analysis, or the presentation itself, but rather is an announcement of the schedule of investor meetings. The document length is 3047 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under Regulatory Filings (RNS) as a general regulatory announcement about investor meetings and use of an existing presentation, not the presentation or report itself.
2025-12-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter dated December 4, 2025, addressed to stock exchanges (BSE and NSE) regarding the schedule of investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The letter informs about upcoming investor meetings and mentions that the Investor Presentation for Q2 & H1FY26 is already publicly available and will be used during these meetings. The document does not contain any financial statements, detailed financial data, or the presentation itself, but rather is an announcement of the schedule of investor meetings. The document length is 3047 characters, which is relatively short and consistent with an announcement rather than a full report or presentation. Therefore, this document fits best under the category of Investor Presentation (IP) as it relates to investor meetings and presentations, but since it only announces the schedule and references an already published presentation, it is more accurately classified as a Regulatory Filing (RNS) because it is a regulatory disclosure about investor meetings and does not contain the presentation itself or detailed financial data.
2025-12-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter dated November 21, 2025, addressed to the listing/compliance departments of BSE and NSE, informing about the schedule of investor meetings under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements. It mentions that an Investor Presentation for Q2 & H1FY26 is already publicly available and will be used in the meetings. The document does not contain any financial statements or detailed financial data itself, but rather is an announcement of upcoming investor meetings and references an existing presentation. The document length is 2891 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about investor meetings and does not contain the investor presentation itself or detailed financial data.
2025-11-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on November 14, 2025, discussing the Q2 and H1 FY26 financial results of GEM Aromatics Limited. It includes detailed remarks from the Managing Director and CFO about the company's performance, financial highlights, operational challenges, and strategic outlook. The text explicitly mentions it is a transcript of the earnings conference call, with a moderator and Q&A format implied. The content is consistent with a Call Transcript (CT) filing, as it contains the full text of the earnings call rather than just a summary or press release. The document length (15,000 characters) and detailed narrative confirm it is not a brief announcement or a report publication notice. Therefore, the appropriate classification is Call Transcript (CT).
2025-11-20 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.